Marijuana Market Offers Variety of Investment Options and

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
4,022
Marijuana Market Offers Variety of Investment Options and Consistent, Long-Lasting Growth Potential

With the North American cannabis market boasting an estimated worth of $7.2 billion in 2016, and new reports projecting CAGR of between 17 percent and 25 percent within the next few years, it’s certainly an exciting time to invest in the marijuana market. Investment opportunities are abundant and diverse with companies like SinglePoint, Inc. (SING) (SING Profile), Innovative Industrial Properties Inc. (IIPR), Insys Therapeutics Inc. (INSY), MassRoots Inc. (MSRT) and Axim Biotechnologies Inc. (AXIM).

The marijuana market is on fire for more reasons than one. First, there’s the huge potential for financial growth. A recent report from New Frontier Data estimates that medical marijuana sales in the United States will increase to $13.3 billion in 2020, and adult recreational marijuana sales are projected to grow to $11.2 billion by the same year. Then, there is the potential for massive job-creation. The same New Frontier Data report estimates that over a quarter of a million jobs will be created within the legal marijuana market by 2020 (1).

A report from leading cannabis market research publisher Arcview Market Research has compared the marijuana market’s explosive growth to the cable television boom of the 1990s and the broadband Internet takeoff of the 2000s. Statements issued by Arcview predict the legalization of marijuana in a significant number of countries within the next decade-and-a-half, crediting the cannabis industry with the most consistent and long-term growth potential the world has ever seen (2).

The possibilities and opportunities are virtually endless within the legalized marijuana market. The business plan of one innovative company, SinglePoint (SING), doesn’t involve actual contact with marijuana plants but rather focuses on providing services to the marijuana industry.

For instance, through its SingleSeed subsidiary, SinglePoint is positioned to offer payment solutions to the cannabis industry. Mobile marketing and payment solutions offered through SingleSeed include cashless ATM, Pay-by-Text™ and text message marketing. While medical marijuana often takes center stage in discussions pertaining to legalization, the power cord for any marijuana business is the ability to conduct financial transactions in what – for the time being – is largely an “unbankable” industry. SinglePoint CEO Greg Lambrecht in a recent Forbes article (3) highlighted the possibility of change under the Trump Administration.

“The current administration has made it very clear they would like to empower the states and Trump has even stated his belief in how medical marijuana can help people. We believe the administration will stick to their word on empowering the states. In Phoenix we have many medical shops, none of which have relayed to us that they are being impacted yet by the administration. The biggest impact the current administration can have in favor of cannabis in the near term would be to give guidelines on how this business can be banked,” stated Lambrecht.

Meanwhile, the SingleSeed.com website is a prime resource for marijuana dispensaries that are seeking merchant payment processing solutions and other business tools.

SinglePoint also recently acquired an interest in the California-based Convectium, a profitable provider of equipment, branding and packaging solutions for the cannabis industry. Convectium is the developer of the first-ever cartridge and vape pen oil filling machines created for wholesale distribution to marijuana dispensaries. The company’s 710Shark and 710Seal machines are able to fill and package more than 100 cartridges or disposable vape pens in 30 seconds. These machines are sold to dispensaries through the EquipCanna.com brand. Convectium further operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in more than 52 countries.

This diversified, “hands-off” approach shields SinglePoint against any legal repercussions, should the federal government surprise with a clampdown on the marijuana industry.

“There’s no reason why they would ever come after us. We provide all of the products these dispensaries need to do business, but we don’t touch the plant,” Lambrecht told The Hill (4).

Another company geared up to capitalized on the legalized marijuana boom, also without touching the plant, is Innovative Industrial Properties Inc. (IIPR). IIPR specializes in acquiring freestanding properties that are used for cultivating licensed medical marijuana and that are operated by state-licensed growers. Once acquired, these properties are leased back to the growers under long-term, net lease agreements. This acquisition strategy acts as a source of capital to these growers. When they sell their real estate locations to IIPR and then lease them back from the company, the growers have an opportunity to redeploy those proceeds into their core operations, thereby yielding a higher return than they would get from owning their real estate.

Also tapping into the cannabis market in an outside-the-box way is MassRoots Inc. (MSRT). MassRoots is a leading technology platform for the marijuana industry. The registered users – currently numbered at over 1 million – can rate cannabis products and strains according to their effectiveness. MassRoots then offers this information in simple-to-use formats to help consumers make informed purchasing decisions at their local marijuana dispensaries.

Cashing in on the medical applications of legalized marijuana is Insys Therapeutics Inc. (INSY). This specialty pharmaceutical company is focused on addressing the clinical inadequacies of existing commercial products through its proprietary sublingual spray technology and its pharmaceutical cannabinoids development capability. Insys is currently marketing two products. The first is Subsys, which is a sublingual Fentanyl spray for breakthrough cancer pain; the second is a generic version of Dronabinol (THC) capsules.

Axim Biotechnologies Inc. (AXIM) is also taking a medical approach in the cannabis market, focusing on researching, developing and producing cannabinoid-based pharmaceuticals and supplements. Axim owns the patent for using chewing gum as a cannabinoid delivery method and has developed two chewing gum-based products. The company’s cannabidiol (CBD)-only Canchew gum is being marketed as a dietary supplement. AXIM will also soon commence phase 3 clinical trials for the combination CBD/THC gum MedChew RX, which is used to treat pain and spasticity associated with multiple sclerosis.

As the marijuana industry blazes forward, it’s clear that opportunities and applications in the cannabis market are plentiful. Innovative companies like SinglePoint.com and others mentioned offer prime investment opportunities for those looking to capitalize in the rapidly growing marijuana field.

Editorial Sources:
(1) Forbes: http://nnw.fm/N283c
(2) Business Insider: http://nnw.fm/yJan6
(3) Forbes: http://nnw.fm/AYj12
(4) The Hill: http://nnw.fm/R7A9h

For more information on Singlepoint visit: Singlepoint, Inc. (SING) or www.SinglePoint.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Singlepoint, Inc. (SING) Stock Research Links

SING Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 3

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 3

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 6

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 4

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
MMRO Achieves URAC AI Accreditation, Ensures Compliance

Updated Category News Views 4

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming the Narcolepsy Market: Innovations Ahead

Updated Category News Views 166

The Evolving Landscape of the Narcolepsy Market The narcolepsy market is undergoing significant changes as it shifts from merely managing symptoms to developing targeted therapies that tackle the root causes of the disorder. Traditionally, treatments focused on alleviating symptoms, but advancements now emphasize addressing the underlying neurochemical issues, primarily...

Continue Reading
UBS Analysts Share Insights on China Stocks Strategies

Updated Category News Views 242

UBS Analysts Offer Insights on China's Equity Market In a recent discussion, UBS strategists have expressed a level of caution regarding China's equity market as they look into the evolving landscape of 2025. It's noted that local A-share investors appear hesitant to seize buying opportunities, influenced by a myriad of factors that create uncertainty in the market....

Continue Reading
Palisade Bio's Special Meeting Cancellation: What You Need to Know

Updated Category News Views 133

Palisade Bio Cancels Special Meeting of Stockholders Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company making strides in developing innovative treatments for autoimmune, inflammatory, and fibrotic diseases. Recently, the company announced an important decision regarding its special meeting of stockholders. The special meeting, originally...

Continue Reading
Vivendi Reports Impressive 4.5% Revenue Growth in 2024

Updated Category News Views 123

Remarkable Revenue Growth for Vivendi Vivendi has announced an impressive increase in its revenues for the first nine months of 2024, emphasizing strong growth across its core business sectors. The company reported a revenue increase of 4.5% at constant currency and perimeter, compared to the same period in the previous year. This growth showcases the resilience and...

Continue Reading
Revolution in Home Renovation Arrives with Spray-Net Franchise

Updated Category News Views 226

Fresh Approach to Home Makeovers Home remodeling isn’t just about slapping on a new coat of paint anymore. In February 2026, Spray-Net is gearing up to launch in Allen, Texas, shaking things up in the renovation game. This venture represents a leap forward—not only for franchise growth but for homeowners who are sick and tired of traditional, drawn-out renovations....

Continue Reading